Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001638820-15-000001
Filing Date
2015-04-27
Accepted
2015-04-27 17:23:17
Documents
1
Effectiveness Date
2015-04-27
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6839
  Complete submission text file 0001638820-15-000001.txt   7980
Mailing Address 701 FIFTH AVENUE, SUITE 5400 SEATTLE WA 98074
Business Address 701 FIFTH AVENUE, SUITE 5400 SEATTLE WA 98074 650-843-5294
Altitude Life Science Ventures Fund II, L.P. (Filer) CIK: 0001638820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-238730 | Film No.: 15796024